BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 19076131)

  • 1. Cancer-specific and non-cancer-related mortality rates in European patients with T1a and T1b renal cell carcinoma.
    Zini L; Patard JJ; Capitanio U; Crepel M; de La Taille A; Tostain J; Ficarra V; Bernhard JC; Ferrière JM; Pfister C; Villers A; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Apr; 103(7):894-8. PubMed ID: 19076131
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
    Crépel M; Jeldres C; Sun M; Lughezzani G; Isbarn H; Alasker A; Capitanio U; Shariat SF; Arjane P; Widmer H; Graefen M; Montorsi F; Perrotte P; Karakiewicz PI
    Urology; 2010 Oct; 76(4):883-8. PubMed ID: 20932408
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radical versus partial nephrectomy: effect on overall and noncancer mortality.
    Zini L; Perrotte P; Capitanio U; Jeldres C; Shariat SF; Antebi E; Saad F; Patard JJ; Montorsi F; Karakiewicz PI
    Cancer; 2009 Apr; 115(7):1465-71. PubMed ID: 19195042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
    Jeldres C; Bensalah K; Capitanio U; Zini L; Perrotte P; Suardi N; Tostain J; Valeri A; Descotes JL; Rambeaud JJ; de La Taille A; Salomon L; Abbou C; Patard JJ; Karakiewicz PI
    BJU Int; 2009 Jun; 103(12):1632-5. PubMed ID: 19545272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
    Capitanio U; Perrotte P; Zini L; Jeldres C; Shariat SF; Isbarn H; Arjane P; Peloquin F; Pharand D; Montorsi F; Karakiewicz PI
    BJU Int; 2009 Sep; 104(6):795-9. PubMed ID: 19389018
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A non-cancer-related survival benefit is associated with partial nephrectomy.
    Sun M; Trinh QD; Bianchi M; Hansen J; Hanna N; Abdollah F; Shariat SF; Briganti A; Montorsi F; Perrotte P; Karakiewicz PI
    Eur Urol; 2012 Apr; 61(4):725-31. PubMed ID: 22172373
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
    Zini L; Perrotte P; Jeldres C; Capitanio U; Pharand D; Arjane P; Lapointe S; Montorsi F; Patard JJ; Karakiewicz PI
    BJU Int; 2008 Dec; 102(11):1610-4. PubMed ID: 18710442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.
    Jeldres C; Patard JJ; Capitanio U; Perrotte P; Suardi N; Crepel M; Ficarra V; Cindolo L; de La Taille A; Tostain J; Pfister C; Albouy B; Colombel M; Méjean A; Lang H; Jacqmin D; Bernhard JC; Ferrière JM; Bensalah K; Karakiewicz PI
    Urology; 2009 Jun; 73(6):1300-5. PubMed ID: 19376568
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capsular involvement in patients undergoing partial nephrectomy for localized renal cell carcinoma: an adverse pathological finding?
    Rouach Y; Delongchamps N; Timsit MO; Verkarre V; Fontaine E; Peyromaure M; Mejean A
    BJU Int; 2010 Mar; 105(5):616-9. PubMed ID: 19681891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Partial nephrectomy for small localized renal cell carcinoma.
    Uchida K; Takahashi A; Masumori N; Yanase M; Itoh N; Tsukamoto T
    Hinyokika Kiyo; 2004 Jun; 50(6):389-95. PubMed ID: 15293735
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
    Crépel M; Jeldres C; Perrotte P; Capitanio U; Isbarn H; Shariat SF; Liberman D; Sun M; Lughezzani G; Arjane P; Widmer H; Graefen M; Montorsi F; Patard JJ; Karakiewicz PI
    Urology; 2010 Feb; 75(2):271-5. PubMed ID: 19962740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
    Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
    BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumour size, tumour complexity, and surgical approach are associated with nephrectomy type in small renal cortical tumours treated electively.
    Broughton GJ; Clark PE; Barocas DA; Cookson MS; Smith JA; Herrell SD; Chang SS
    BJU Int; 2012 Jun; 109(11):1607-13. PubMed ID: 21939493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nephron sparing surgery for appropriately selected renal cell carcinoma between 4 and 7 cm results in outcome similar to radical nephrectomy.
    Leibovich BC; Blute M; Cheville JC; Lohse CM; Weaver AL; Zincke H
    J Urol; 2004 Mar; 171(3):1066-70. PubMed ID: 14767272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postoperative renal function after partial nephrectomy for renal cell carcinoma in patients with pre-existing chronic kidney disease: a comparison with radical nephrectomy.
    Takagi T; Kondo T; Iizuka J; Kobayashi H; Hashimoto Y; Nakazawa H; Ito F; Tanabe K
    Int J Urol; 2011 Jun; 18(6):472-6. PubMed ID: 21481013
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytoreductive nephron-sparing surgery does not appear to undermine disease-specific survival in patients with metastatic renal cell carcinoma.
    Hutterer GC; Patard JJ; Colombel M; Belldegrun AS; Pfister C; Guille F; Artibani W; Montorsi F; Pantuck AJ; Karakiewicz PI
    Cancer; 2007 Dec; 110(11):2428-33. PubMed ID: 17941033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcome of nephron-sparing surgery for T1b renal cell carcinoma.
    Joniau S; Vander Eeckt K; Srirangam SJ; Van Poppel H
    BJU Int; 2009 May; 103(10):1344-8. PubMed ID: 19040528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiofrequency ablation versus partial nephrectomy in patients with solitary clinical T1a renal cell carcinoma: comparable oncologic outcomes at a minimum of 5 years of follow-up.
    Olweny EO; Park SK; Tan YK; Best SL; Trimmer C; Cadeddu JA
    Eur Urol; 2012 Jun; 61(6):1156-61. PubMed ID: 22257424
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.
    Sun M; Bianchi M; Trinh QD; Hansen J; Abdollah F; Hanna N; Tian Z; Shariat SF; Montorsi F; Perrotte P; Karakiewicz PI
    BJU Int; 2013 Jan; 111(1):67-73. PubMed ID: 22612472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.